Literature DB >> 23419083

The adverse impact of type 2 diabetes on brain volume in heart failure.

Michael L Alosco1, Adam M Brickman, Mary Beth Spitznagel, Erica Y Griffith, Atul Narkhede, Naftali Raz, Ronald Cohen, Lawrence H Sweet, Lisa H Colbert, Richard Josephson, Joel Hughes, Jim Rosneck, John Gunstad.   

Abstract

OBJECTIVE: Heart failure (HF) is associated with structural brain abnormalities, including atrophy in multiple brain regions. Type 2 diabetes mellitus (T2DM) is a prevalent comorbid condition in HF and is associated with abnormalities on neuroimaging in other medical and elderly samples. The current study examined whether comorbid T2DM exacerbates brain atrophy in older adults with HF.
METHODS: Seventy-five older adults with HF underwent an echocardiogram and completed a brief cognitive test battery. Participants then underwent brain magnetic resonance imaging (MRI) to quantify total brain volumes, cortical lobar volumes, and white matter hyperintensities (WMH).
RESULTS: Approximately 30% of HF patients had a comorbid T2DM diagnosis. A series of multivariate analyses of covariance (MANCOVAs) adjusting for medical and demographic characteristics and intracranial volume showed that HF patients with T2DM had smaller total brain, gray matter, and subcortical gray matter volume than those without such history. No between-group differences emerged for WMH. Persons with T2DM also had smaller cortical lobar volumes, including in frontal, temporal, and parietal lobes. Follow-up analyses revealed that smaller total and cortical lobar brain volumes and WMH were associated with poorer performance on measures of global cognitive status, attention, executive functions, and memory.
CONCLUSIONS: T2DM is associated with smaller total and cortical lobar brain volumes in patients with HF, and these structural brain indices were associated with cognitive test performance. Prospective studies that directly monitor glucose levels are needed to confirm our findings and clarify the mechanisms by which T2DM adversely impacts brain atrophy in this population.

Entities:  

Mesh:

Year:  2013        PMID: 23419083      PMCID: PMC3633205          DOI: 10.1080/13803395.2013.771617

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  53 in total

Review 1.  Vascular dementia prevention: a risk factor analysis.

Authors:  Gustavo C Román
Journal:  Cerebrovasc Dis       Date:  2005-12-02       Impact factor: 2.762

2.  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Authors:  R C Arnau; M W Meagher; M P Norris; R Bramson
Journal:  Health Psychol       Date:  2001-03       Impact factor: 4.267

3.  Cerebral blood flow in patients with chronic heart failure before and after heart transplantation.

Authors:  N Gruhn; F S Larsen; S Boesgaard; G M Knudsen; S A Mortensen; G Thomsen; J Aldershvile
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

4.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

5.  Brain magnetic resonance imaging abnormalities in patients with heart failure.

Authors:  Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein
Journal:  Eur J Heart Fail       Date:  2007-08-23       Impact factor: 15.534

6.  Cognitive test performance and brain pathology.

Authors:  Stacy L Serber; Rajesh Kumar; Mary A Woo; Paul M Macey; Gregg C Fonarow; Ronald M Harper
Journal:  Nurs Res       Date:  2008 Mar-Apr       Impact factor: 2.381

7.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

8.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

9.  The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes.

Authors:  Y Su; X-M Liu; Y-M Sun; H-B Jin; R Fu; Y-Y Wang; Y Wu; Y Luan
Journal:  Int J Clin Pract       Date:  2008-06       Impact factor: 2.503

10.  Neuroimaging and correlates of cognitive function among patients with heart failure.

Authors:  Raymond L C Vogels; Joukje M Oosterman; Barbera van Harten; Alida A Gouw; Jutta M Schroeder-Tanka; Philip Scheltens; Wiesje M van der Flier; Henry C Weinstein
Journal:  Dement Geriatr Cogn Disord       Date:  2007-10-15       Impact factor: 2.959

View more
  8 in total

1.  Reduced Gray Matter Volume Is Associated With Poorer Instrumental Activities of Daily Living Performance in Heart Failure.

Authors:  Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Atul Narkhede; Erica Y Griffith; Ronald Cohen; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad
Journal:  J Cardiovasc Nurs       Date:  2016 Jan-Feb       Impact factor: 2.083

2.  Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.

Authors:  Hesam Parsa; Mahdi Ramezani; Parsa Gholipour; Alireza Komaki
Journal:  Neurochem Res       Date:  2022-04-29       Impact factor: 3.996

Review 3.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

4.  Daily Physical Activity Is Associated with Subcortical Brain Volume and Cognition in Heart Failure.

Authors:  Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Erica Y Griffith; Atul Narkhede; Joel Hughes; John Gunstad
Journal:  J Int Neuropsychol Soc       Date:  2015-11       Impact factor: 2.892

5.  Regional Brain Gray Matter Changes in Patients with Type 2 Diabetes Mellitus.

Authors:  Bhaswati Roy; Luke Ehlert; Rashmi Mullur; Matthew J Freeby; Mary A Woo; Rajesh Kumar; Sarah Choi
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

6.  Obesity and cognitive dysfunction in heart failure: the role of hypertension, type 2 diabetes, and physical fitness.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Eur J Cardiovasc Nurs       Date:  2014-05-14       Impact factor: 3.908

7.  Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models.

Authors:  Juan Jose Ramos-Rodriguez; Sara Molina-Gil; Oscar Ortiz-Barajas; Margarita Jimenez-Palomares; German Perdomo; Irene Cozar-Castellano; Alfonso Maria Lechuga-Sancho; Monica Garcia-Alloza
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

8.  Extending Inferential Group Analysis in Type 2 Diabetic Patients with Multivariate GLM Implemented in SPM8.

Authors:  Fábio S Ferreira; João M S Pereira; João V Duarte; Miguel Castelo-Branco
Journal:  Open Neuroimag J       Date:  2017-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.